18 November 2016
The Royal North Shore Hospital and Kolling Institute recently hosted Parkinson’s Disease Information Day, Parkinson’s Disease (PD) is the second most common neurological disorder in Australia after dementia and it is estimated to affect 70,000 individuals in Australia alone. This year, the focus was on current and future strategies for the care and treatment of Parkinson’s Disease.
Leading the presentations and the hosts of the day included Professor Carolyn Sue, head of the Neuroscience Research Group at the Kolling Institute as well as Clinical Nurse Specialist Sue Williams. Professor Sue and colleagues provided an overview of Parkinson’s Disease and when to consider advanced therapies such as Apomorphine, Duodopa, and Deep Brain stimulation.
The day was a success with thanks especially to the great turn-out of patients and carers interested in PD who came to hear all about the services provided at the RNSH and updates on research conducted at the Kolling Institute.